A prospective study of ruxolitinib in chronic graft versus host disease patients
Latest Information Update: 20 Jul 2020
At a glance
- Drugs Ruxolitinib (Primary) ; T-lymphocyte cell therapy (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 20 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association